Skip to main content
All lobbying filings

CHILDREN'S HEALTHCARE OF ATLANTA

Lobbying for CHILDREN'S HEALTHCARE OF ATLANTA

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Georgia · House · Senate · $100,000.00 expenses · posted Jul 16, 2026

Official filing document

 Bills named in this filing 3
  • HR 2107
    Children’s Hospital GME Support Reauthorization Act of 2025
  • HR 9260
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
 Lobbying activity 2
Health Issues

Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally Federal telehealth policy generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions

Budget/Appropriations

Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies. Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027) Title II, regarding Children's Hospitals Graduate Medical Education (CHGME) program, National Institutes of Health funding, sickle cell disease research, and other programs related to pediatric healthcare. Implementation of H.R.1, Sections 71115, 71116, regarding Medicaid funding.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem